This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

An Update

Jean-Claude Bystryn, MD; Natasha M. Steinman, MD

Arch Dermatol. 1996;132(2):203-212.

Abstract
Systemic corticosteroids remain the mainstay of therapy for pemphigus. Their use has transformed what was almost invariably a fatal illness into one whose mortality is now below 10%. Unfortunately, the high doses and prolonged administration of corticosteroids that are often needed to control the disease result in numerous side effects, many of which are serious. Most patients who die of pemphigus at present die of complications of therapy. This has led to a continued search for alternative treatments that might reduce the need for steroids. Those treatments now in use are usually given in combination with steroids and, for that reason, are referred to as adjuvant therapies. This article summarizes progress in the adjuvant therapy of pemphigus since the last review of this subject 10 years ago.

(Arch Dermatol. 1996;132:203-212)

Author Affiliations
From The Ronald O. Perelman Department of Dermatology, New York University Medical Center, New York, NY.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus
Joly et al.
NEJM 2007;357:545-552.
ABSTRACT | FULL TEXT  

A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus.
Beissert et al.
Arch Dermatol 2006;142:1447-1454.
ABSTRACT | FULL TEXT  

Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin
Ahmed et al.
NEJM 2006;355:1772-1779.
ABSTRACT | FULL TEXT  

Prevention of Osteoporosis Associated With Chronic Glucocorticoid Therapy
Heffernan et al.
JAMA 2006;295:1300-1303.
FULL TEXT  

Treatment of Refractory Pemphigus Vulgaris With Rituximab (Anti-CD20 Monoclonal Antibody)
Dupuy et al.
Arch Dermatol 2004;140:91-96.
ABSTRACT | FULL TEXT  

Pathology Quiz Case 2--Diagnosis
Arch Otolaryngol Head Neck Surg 2003;129:256-257.
FULL TEXT  

PEMPHIGUS VULGARIS: UPDATE ON ETIOPATHOGENESIS, ORAL MANIFESTATIONS, AND MANAGEMENT
Scully and Challacombe
CROBM 2002;13:397-408.
ABSTRACT | FULL TEXT  

Corticosteroid-Sparing Effect of Intravenous Immunoglobulin Therapy in Patients With Pemphigus Vulgaris
Sami et al.
Arch Dermatol 2002;138:1158-1162.
ABSTRACT | FULL TEXT  

Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit
Wozniacka et al.
Lupus 2002;11:71-81.
ABSTRACT  

Penile Pemphigus
Sami and Ahmed
Arch Dermatol 2001;137:756-758.
ABSTRACT | FULL TEXT  

Ineffectiveness of Cyclosporine as an Adjuvant to Corticosteroids in the Treatment of Pemphigus
Ioannides et al.
Arch Dermatol 2000;136:868-872.
ABSTRACT | FULL TEXT  

Immune Modulation in Pemphigus Vulgaris: Role of CD28 and IL-10
Toto et al.
J. Immunol. 2000;164:522-529.
ABSTRACT | FULL TEXT  

Methotrexate as an Adjuvant Treatment for Pemphigus Vulgaris
Smith and Bystryn
Arch Dermatol 1999;135:1275-1276.
FULL TEXT  

Pemphigus--Diseases of Antidesmosomal Autoimmunity
Udey and Stanley
JAMA 1999;282:572-576.
FULL TEXT  

Is Mycophenolic Acid Effective for the Treatment of Pemphigus?
Bystryn et al.
Arch Dermatol 1999;135:854-855.
FULL TEXT  

Pulse Intravenous Cyclophosphamide Therapy in Pemphigus
Fleischli et al.
Arch Dermatol 1999;135:57-61.
ABSTRACT | FULL TEXT  

Therapy of Pemphigus Vulgaris
Stanley
Arch Dermatol 1999;135:76-78.
FULL TEXT  

Treatment of Pemphigus With Gold
Pandya and Dyke
Arch Dermatol 1998;134:1104-1107.
ABSTRACT | FULL TEXT  

Pulse Glucocorticoid Therapy: The 'Big Shot' Revisited
Roujeau
Arch Dermatol 1996;132:1499-1502.
ABSTRACT  

Curative Treatment for Pemphigus
Pasricha and Khaitan
Arch Dermatol 1996;132:1518-1519.
ABSTRACT